首页>>国际

中国官方:依法惩治预防打着“新时代西部大开发”幌子实施非法金融活动

2022-08-10 11:44:40 | 来源:张掖新闻网
小字号

  中新社北京8月9日电 (记者 张素)中国最高人平易近查察院9日对外发布的一份司法定见提出,依法惩办和预防打着“新时期西部年夜开辟”幌籽实施的各类不法金融勾当和涉金融机构、上市公司、中介机构等金融犯法案件。   《最高人平易近查察院关于撑持和办事保障贵州在新时期西部年夜开辟上闯新路的定见》共14条,此中环绕“办事保障重点行业范畴平安”,要求查察机关会同金融监管部分增强金融背法犯法溯源治理,有用催促其梗塞风险缝隙,从泉源提防化解金融风险。   这份定见同时强调,环绕贵州介入“一带一路”扶植、区域周全经济火伴关系协议(RCEP)实行,查察机关要强化涉外商投资、数字商业、跨区域或跨境电商、外贸、海外仓等商业胶葛案件诉讼监视,办事保障增进商业投资自由化便当化。   为撑持办事保障贵州在新时期西部年夜开辟上闯新路,司法定见提出多项办法。好比要求查察机关加年夜对特点优势农产物等地舆标记、知名品牌庇护力度,助力“黔货出山”;又如提出加年夜对世界天然遗产地、平易近族村寨、传统村子和汗青文假名村名镇等公益庇护力度,助力晋升“山地公园省·多彩贵州风”旅游品牌影响力,等等。   这份定见还提出多项立异行动,包罗“摸索成立碳汇抵偿等生态查察机制”“扶植全国查察机关年夜数据法令监视研发立异基地”等。   据悉,最高检将与贵州省察察院对口成立平常对接机制,细化具体撑持办法,以期“为查察机关办事保障新时期西部年夜开辟构成新款式建立样板”。(完) 【编纂:苏亦瑜】

(责编:adkin)

分享让更多人看到

揭秘!qq上约的600一次是真的吗(更多内幕请戳)

中老铁路开通以来进出口货物已突破百万吨

2022-08-10 12:02:41 | 来源:益阳市新闻网
小字号

  新华社昆明8月9日电(记者庄北宁)记者从昆明海关得悉,截至8月7日,昆明海关已监管验放1996列中老铁路国际货色列车,进出口货色总量达102.1万吨,货值约91.4亿元。   据介绍,中老铁路客岁12月开通以来,国内已有江苏、内蒙古等30个省(区、市)经由过程中老铁路快速连通老挝、泰国、新加坡等国度和地域,跨境货色运输能力进一步晋升。   为保障中老铁路国际货色列车高效运行,昆明海关在优化监管办法、完美港口功能、强化表里联动、办事新业态成长等方面靶向发力,全力撑持中老铁路跨境物流运能不竭晋升。 【编纂:李岩】

(责编:adkin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2022
  • #CGT Asia 2022
  • August 9th-10th
  • Shanghai China

Asia Cell & Gene Therapy Innovation Summit 2022

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Cell Therapy, Gene Therapy, Innovative Therapy, Next Generation Oncolytic Virus, End to End Development, CDMO, CRO, Regulation, IND Application, GLP, Clinical Trail Design, Continuous Production Process, GMP, Immunomodulation, Viral Vectors, High-Throughput Screening, Transfection, Combination Therapy, IVD, Digital PCR, CRISPR/CAS9 Gene Editing, Humanized Animal models, mRNA Tumor Vaccines, Nanoantibody, BsAbs, Customization Manufacturing, Tumor Microenvironment, Stem Cell Therapy, Recombinant Protein, Targets

Event Highlights

Cell Therapy Industrialization and Commercialization Module Strategy

TCR-T Therapy Market Prospects and Development Trends

Targets Selection and Direction of TCR-T Therapeutic Products

Development Key Points of Universal CAR-NK Cell Therapy Products

iPSC Personalized Diagnosis and Treatment and Application

Research and Development of mRNA Drug and Delivery Vector Technology

Viral Vector Process and Optimization Plan

Difficulty in the Development of Gene Therapy Drugs for Rare Diseases

Current Status of Circular RNA R&D

Who Should Attend

Biopharmaceutical CompaniesPre-Clinical R&DClinical R & DVaccine/Antibody CompaniesCell Therapy CompaniesGene Therapy CompaniesScientific Research InstitutesBiotechnology CompaniesLaboratory Equipment SuppliersDrug TestingAnalytical ServicesProduction Solution Providers (Upstream, Downstream) Life Science and Analytical EquipmentDiagnostic and Testing EquipmentExternal AuthorizationProtein Drugs CompaniesContract Service Providers (CRO, CMO, CDMO) Import and Export EnterprisesHVAC Facilities and Cleanroom Equipment SuppliersGovernment Representatives/Trading InstitutionsPreparation MachineryPharmaceutical EngineeringLaw and Regulation FirmsDrug Delivery System ManufacturersThird Party Logistics ProvidersAutomation/RobotCold Chain Packaging CompaniesPackaging MachineryIndustrial ParksLaboratory ServicesLaboratory/Biochemical/Analytical InstrumentsFine Chemical ManufacturersEnvironmental ProtectionIntermediate ManufacturersRegulatory ServicesSupply ChainNew Drug R & D CompaniesConsultant Companies


Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Speakers

Dr. Xingwang XIE
Dr. Xingwang XIE

CEO

Corregene

Dr. Guojie YE
Dr. Guojie YE

CSO

EXEGENESIS BIO

Dr. Jinghui DOU
Dr. Jinghui DOU

CSO

TriApex Laboratories Co. LTD

Dr. Wenqiang YU
Dr. Wenqiang YU

Senior PI

Institutes of Biomedical Sciences Fudan University

Yan CHANG
Yan CHANG

President

INNOSTAR - National Shanghai Center for New Drug Safety Evaluation and Research

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President, R&D, Catalog Product

GenScript

Mr. Hongdong YU
Mr. Hongdong YU

Director of Biological Culture Scenario

Haier Biomedical

Xiaochun Wan
Xiaochun Wan

CEO

Shenzhen BinDeBio Ltd.

Kangjian ZHANG
Kangjian ZHANG

Co-Founder, Director and GM

Yuansong Bio

Dr. Andrew LIN
Dr. Andrew LIN

Founder & CEO

Lingyi Biotherapeutics Co. Ltd

Mo MA
Mo MA

CEO

Shenzhen Eureka Biotechnology Co., Limited

Dr. Jinqiao WAN
Dr. Jinqiao WAN

Vice President of R&D Chemistry Center

HitGen Inc.

Chunying Li
Chunying Li

Technical Application Liaison, China

Mission Bio

Hongjiu DAI
Hongjiu DAI

CEO

Nanjing Kaedi Biotherapeutics

Prof. Evelyne Yehudit Bischof
Prof. Evelyne Yehudit Bischof

Professor Doctor

Shanghai University of Medicine and Health Sciences

Yongzhen LIU
Yongzhen LIU

Deputy Director of Center for Drug Safety Evaluation

Shanghai Institute of Materia Medica

Ryan CAWOOD
Ryan CAWOOD

Chief Scientific Officer

WuXi Advanced Therapies

 Lei ZHANG
Lei ZHANG

R&D VP

Neukio Biotherapeutics

Jimin GAO
Jimin GAO

Professor

Wenzhou Medical University

Ke ZHANG
Ke ZHANG

Chief Scientific Officer

SCG Cell

Yun YANG
Yun YANG

CTO

CirCode Bio

Yang WANG
Yang WANG

Director of Research and Development

Wuhan Binhui Biopharmaceutical

Xiaoxi XU
Xiaoxi XU

Director of In Vitro

Crown Bioscience

Mark FANG
Mark FANG

CQO

Shanghai Zhimi Medical Technology

Adam ZHAO
Adam ZHAO

President

AnlongBio

Yunxiang ZHU
Yunxiang ZHU

Vice President

CANbridge Pharma

Frank GAO
Frank GAO

Chief Strategy Officer

BRL Medicine

Tianhong XU
Tianhong XU

CEO

Base Therapeutics

Emily TAN
Emily TAN

Chief Operating Officer

Bennu Biotherapeutics

Fred MAO
Fred MAO

Partner & Managing Director

Frost & Sullivan

Yarong LIU
Yarong LIU

Founder

Grit Biotechnology

Lei SUN
Lei SUN

CTO

GeneMind

John LU
John LU

President & CEO

HebeCell

Yi ZHU
Yi ZHU

Chief Executive Officer

Hillgene

Grace Zhou
Grace Zhou

CEO

ImmVira Pharma

Xiaoqi QI
Xiaoqi QI

Associate Regional Marketing Manager

10x Genomics

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
化学加
人民医生网
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
医诺医学
美通社
动脉网
医疗器械创新网
化学网
中国仪器批发网
再生医学
盖德化工网
大健康网
阿仪网
张通社
测序宝
基因君
51健康网
中国健康咨询网
爱爱医
来宝网
露森科研
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now